LTFS
CSCI

Ladenburg Thalmann Financial Services’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Hold
0
– – – 5532
2019
Q3 		– Hold
0
– – – 5477
2019
Q2 		– Hold
0
– – – 5440
2019
Q1 		– Hold
0
– – – 5366
2018
Q4 		– Hold
0
– – – 5359
2018
Q3 		– Hold
0
– – – 5338
2018
Q2 		– Hold
0
– – – 5162
2018
Q1 		– Hold
0
– – – 5219
2017
Q3 		– Sell
-5
Closed -$1K – 5038
2017
Q2 		$1K Hold
5
– – ﹤0.01% 4784
2017
Q1 		$2K Hold
5
– – ﹤0.01% 4603
2016
Q4 		$2K Hold
5
– – ﹤0.01% 4560
2016
Q3 		$2K Hold
5
– – ﹤0.01% 4520
2016
Q2 		$2K Hold
5
– – ﹤0.01% 4442
2016
Q1 		$2K Hold
5
– – ﹤0.01% 4411
2015
Q4 		$2K Buy
+5
New +$3.14K ﹤0.01% 4392

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CSCI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its COSCIENS Biopharma Inc. Common Stock (CSCI) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5532.

Ladenburg Thalmann Financial Services first reported a position in CSCI in Q4 2015 and has held it in 7 quarters since. The position peaked at $2K in Q1 2017. 24 funds tracked by Wall St. Rank hold CSCI as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 0 shares of COSCIENS Biopharma Inc. Common Stock worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its COSCIENS Biopharma Inc. Common Stock share count unchanged in Q4 2019.
  • COSCIENS Biopharma Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5532 holding.
  • Ladenburg Thalmann Financial Services first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and has held it in 7 quarters since.
  • Ladenburg Thalmann Financial Services's COSCIENS Biopharma Inc. Common Stock position peaked at $2K in Q1 2017.
  • 24 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.